Company Statement

Mission Statement

Biocompatibles International plc is a medical technology company focused on drug device Combination Products principally for use in Oncology.  We therefore come to work to play our part in reducing patient illness, pain and discomfort.  Our shareholders will share in our success.

People and Process

  • We have talented, committed and competent people with a positive attitude and a sense of urgency.
  • The elements of Biocompatibles Process Improvement develop our people, build a shared commitment to continuous improvement and help develop the business.
  • We seek to develop our people by delegating responsibility, providing continuous training and demonstrating our preference for internal appointments.
  • Our Reward and Recognition programmes indicate the importance we attach to teamwork.
  • We recruit and promote on merit without regard to age, gender, race, nationality, faith, sexual orientation or disability.
  • We work with clear operating procedures and simple transparent processes.
  • We provide each other with relevant, complete, concise and timely information.
  • When we do things, we do them properly.  We deliver – especially our Annual Business and Quality Goals.
  • Implementation and leadership of these principles has a direct bearing on career progression and compensation.

Quality

  • Our focus on Continuous Quality Improvement revolves around continuously asking:  Who are our customers?  What are their needs?  How are we doing?  What can we do better?
  • We identify and monitor our key processes through our quality objectives using process indicators.
  • We meet clinical expectations with our product specifications by implementation of capable and stable design and manufacturing systems.
  • Our systems comply with the requirements of European, US and other regulatory bodies.

Ethics

  • We comply with legal and regulatory requirements and show personal integrity in our dealings with each other and the outside world.
  • We work to reduce any adverse impact of our business on the environment and provide a safe working environment.
  • We seek to minimise the use of pre-clinical trials and present clinical data with due regard for statistical significance.
  • We embrace the responsibility inherent in supplying healthcare products.